Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Atherosclerotic lower extremity peripheral artery disease (PAD) is increasingly recognized
as an important cause of cardiovascular morbidity and mortality that affects >230 million …

Background Elevated triglyceride-rich lipoprotein (TRL) and small-dense low-density
lipoprotein (sdLDL) particles are hallmarks of atherogenic dyslipidemia, and their cholesterol …

Background: The combination of statin therapy and PCSK9 (proprotein convertase subtilisin/kexin
type 9) inhibition markedly lowers low-density lipoprotein cholesterol (LDL-C) and …

Background: The mechanism of adverse limb events associated with peripheral artery
disease remains incompletely understood. We investigated whether microvascular disease is …

As biologic, epidemiologic, and clinical trial data have demonstrated, inflammation is a key
driver of atherosclerosis. Circulating biomarkers of inflammation, including high-sensitivity C-…

Background: Despite strong and consistent prospective associations of elevated low-density
lipoprotein (LDL) cholesterol concentration with incident coronary and cerebrovascular …

Inflammation is a critical pathway in the pathogenesis of atherosclerosis. Previous studies
have shown that plasma levels of high-sensitivity C-reactive protein (hsCRP), a marker of …

Background: Lipoprotein-related traits have been consistently identified as risk factors for
atherosclerotic cardiovascular disease, largely on the basis of studies of coronary artery …